Supplemental material
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 3
Research Paper
Characterization of the UK anthrax vaccine and human immunogenicity
Tapasvi Modia Porton Biopharma Limited, Development, Porton Down, Salisbury, Wiltshire, UKCorrespondence[email protected]
https://orcid.org/0000-0002-9079-5657
https://orcid.org/0000-0002-9079-5657, David Gervaisa Porton Biopharma Limited, Development, Porton Down, Salisbury, Wiltshire, UKhttps://orcid.org/0000-0002-4996-3217
https://orcid.org/0000-0002-4996-3217, , , , Konstantinos Thalassinosb Institute of Structural and Molecular Biology, Division of Biosciences, Darwin Building Room 101A, University College London, London, UK;c Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, London, UKhttps://orcid.org/0000-0001-5072-8428
https://orcid.org/0000-0001-5072-8428 & Adrian Shepherdc Department of Biological Sciences and Institute of Structural and Molecular Biology, Birkbeck, University of London, London, UKhttps://orcid.org/0000-0003-0194-8613
https://orcid.org/0000-0003-0194-8613 show all